β-Nicotinamide mononucleotide

We are β-Nicotinamide mononucleotide CAS:1094-61-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:β-Nicotinamide mononucleotide
CAS.NO:1094-61-7
Synonyms:β-Nicotinamide mononucleotide
NMN zwitterion
NMN
Beta-Nicotinamide Mononucleotide
Nicotinamide D-ribonucleotide
 
Physical and Chemical Properties:
Molecular Formula C11H15N2O8P
Molecular Weight 334.219
Storage condition 2-8°C
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer 
 
requirements
Storage:Store in a cool, ventilated place
Application: Targeting anti-aging and repairing cells.

β-Nicotinamide mononucleotide


Related News: ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses.Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.69045-82-5 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.4-Trifluoromethylbenzoylchloride Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.

Related Products
Product Name
3,5-Difluorobenzyl bromide View Details
1-(4-methylphenyl)sulfonyl-1,2,4-triazole View Details
9-Bromoanthracene View Details
3,4-DICHLOROBENZOTRIFLUORIDE Cas:328-84-7 manufacturer 1-chloro-8-phenyldibenzo[b,d]furan Cas:2379717-75-4 manufacturer 1,3-Diisopropenylbenzene Cas:3748-13-8 manufacturer 1-(2-fluoro-6-(trifluoromethyl)benzyl)urea Cas:830346-46-8 manufacturer Lithium iodide trihydrate Cas:7790-22-9 manufacturer